2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$69.97+$0.21 (+0.30%)
Price as of Sep 11, 2026 7:34 PM EDT- $2.4BMarket Cap
- 43.30%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$69.97+$0.21 (+0.30%)
NKTR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $69.76 | ||
Change | -$0.89 (-1.26%) | ||
Open | $71.41 | ||
High | $71.41 | ||
Low | $68.35 | ||
Previous Close | $70.65 | ||
Volume | 873,805 | ||
30-Day Average Volume | 619,386 | ||
1-Week Change | -5.97% | ||
1-Month Change | -7.60% | ||
1-Year Change | 43.30% | ||
3-Year Change | 615.49% | ||
5-Year Change | -70.84% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $1.1B | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $10.1M | ||
Net Income | -$40.6M | ||
Free Cash Flow | -$75.9M | ||
EBIT | -$40.6M | ||
EBITDA | -$40.5M | ||
Net Working Capital | $668.4M | ||
EPS | -$1.23 | ||
Enterprise Value/EBITDA | -58 | ||
Enterprise Value/Revenue | 231 | ||
P/B | 3 | ||
P/E | -57 | ||
PEG | -2 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue